JAK2 and prostate adenocarcinoma: This suggestion is reinforced by the fact that the expression of LEP, leptin receptor (LEPR) and its main downstream signaling genes (JAK2, STAT3) is reduced in prostate adenocarcinoma (Figure 11), suggesting that this system is involved in the mechanism of apoptosis defense in proliferating tumor cells.